Indeed, inhibition of PPAR-α expression is reported to abolish the protective effects of human fibroblast growth factor 19 (FGF19) on obesity-induced sarcopenia [90]. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.